by Grace-Marie Turner | Forbes | June 1, 2020 | Bundled payments are a good idea, until they aren’t—for patients. The idea of paying a combined price rather than piecemeal for a routine medical treatment or procedure has gained traction as a way of driving efficiency. You wouldn’t want to buy a car by ordering a carburetor, ignition, fuel tank, braking system, etc. But when the government … [Read more...] about Bundled Payment For Dialysis Patients Can Block Access To Innovative Treatments
Destructive New Subsidies
Obamacare Subsidies: Six Reasons Congress Should Not Make Temporary Increases Permanent By Doug BadgerThe Heritage Foundation, May 26, 2021 The recently enacted American Rescue Plan Act spent an estimated $90 billion on free health insurance for the unemployed and on temporarily increasing Obamacare premium subsidies. That temporary expansion made some of the nation’s highest-paid workers … [Read more...] about Destructive New Subsidies
Welcome, Laura!
Many of you know that a key project of the Galen Institute since our inception is facilitating the work of the Health Policy Consensus Group, an affiliation that has grown to include more than 275 leaders in the free-market health care and health policy space. And this month, we welcome Laura Trueman to bring her extraordinary expertise in consensus-building and outreach to the Galen team … [Read more...] about Welcome, Laura!
A Disaster for Life-Saving Innovation
by Grace-Marie Turner | RealClear Health | The Biden administration has taken a bulldozer to intellectual property rights in announcing it will not protect COVID-19 creator companies, auspiciously to hasten access to vaccines in developing countries. Instead of pulling this political stunt, officials should listen to the companies that already are on track to provide near-universal access to their … [Read more...] about A Disaster for Life-Saving Innovation
A Biden Administration Regulatory ‘Fix’ to the ‘Family Glitch’ Would Be Illegal and Harmful
Biden administration officials reportedly are exploring whether they can use the regulatory process to “fix” the so-called family glitch in the Affordable Care Act to extend ACA premium tax credits to some employees’ family members who currently are not eligible. But Galen Senior Fellow Brian Blase explains both why the Biden administration lacks the legal authority for such a fix as well … [Read more...] about A Biden Administration Regulatory ‘Fix’ to the ‘Family Glitch’ Would Be Illegal and Harmful
Undoing Progress
While Congress failed to pass legislation in 2017 that would chart a new path for health reform, the Trump administration made important progress through administrative actions to give consumers more affordable choices for health insurance and offer states more options to take care of vulnerable patients with high health costs.The Biden administration is working to pull the plug on many of these … [Read more...] about Undoing Progress
The “Family Glitch” Administrative Fix Under Consideration By The Biden Administration Remains Both Illegal And Harmful
by Brian Blase | Forbes | The Galen Institute released a short analysis I conducted explaining why an administrative fix to the Affordable Care Act’s (ACA’s) so-called family glitch would be both illegal and harmful. Dania Palanker, with the Georgetown University Health Policy Institute, criticized the analysis I conducted, saying it was not based on the administrative fix the Biden … [Read more...] about The “Family Glitch” Administrative Fix Under Consideration By The Biden Administration Remains Both Illegal And Harmful
The benefits of government requiring health care price transparency
by Brian Blase | The Hill | One major difference between the health care sector and other economic sectors is the opacity and complexity of prices for medical goods and services. While in other sectors, prices for similar goods or services are generally analogous, health care prices can vary widely depending on where the service is received and who is paying. For this reason, shopping in … [Read more...] about The benefits of government requiring health care price transparency